RSS   Newsletter   Contact   Advertise with us

Sequenom welcomes Catherine J. Mackey to board

Staff writer | San Diego, Ca., USA | June 19, 2015
Catherine J. MackeyJune 19, 2015, San Diego, Ca., USA - Sequenom, Inc., a life sciences company, announced that its shareholders elected Catherine J. Mackey as a new member of its board of directors.
Dr. Mackey has also been appointed to the Audit and Nominating and Corporate Governance committees of the Company's Board of Directors. Dr. Mackey is currently the Chief Executive Officer of CYPrus Therapeutics, Inc., a privately-held small molecule pharmaceutical development company.

She is a Special Advisor to Fortis Advisors LLC, and serves on the Scientific Advisory Boards of FHOOSH, Inc. and Cypher Genomics. In addition, Dr. Mackey is a director and a member of the Finance and Audit & Compliance Committees of Rady Children's Hospital and is past-chair of CONNECT.

Dr. Mackey currently serves on the boards of privately-held companies Cour Pharmaceutical Development Company (Chair), Evolve Biosystems, Inc. and Viventia Bio, Inc.

Prior to her current roles, Dr. Mackey served as the Senior Vice President of Worldwide Research and Development at Pfizer Inc. from 2001 through 2010 and is credited with leading Pfizer's La Jolla Labs to become one of Pfizer's most successful R&D sites.

Before that, Dr. Mackey was Vice President of Strategic Alliances at Pfizer's R&D headquarters in Connecticut and the Leader of Genomic and Proteomic Sciences at Pfizer. Leading up to her time at Pfizer, Dr. Mackey held positions of increasing responsibility for DEKALB Genetics including Vice President and Head of Research and Development.

Dr. Mackey received her B.S. and Ph.D. degrees in microbiology from Cornell University.